B Seltzer

Summary

Affiliation: Tulane University
Country: USA

Publications

  1. ncbi request reprint Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: a comparative study
    B Seltzer
    Department of Psychiatry and Neurology, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA
    Neuropsychiatry Neuropsychol Behav Neurol 14:122-9. 2001
  2. ncbi request reprint Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial
    Ben Seltzer
    Department of Psychiatry and Neurology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112 2699, USA
    Arch Neurol 61:1852-6. 2004
  3. ncbi request reprint Donepezil: a review
    Ben Seltzer
    Tulane University School of Medicine, Department of Psychiatry and Neurology, 1430 Tulane Avenue HC82, New Orleans, Louisiana 70112, USA
    Expert Opin Drug Metab Toxicol 1:527-36. 2005
  4. ncbi request reprint Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment
    B Seltzer
    Alzheimer s Disease and Memory Disorders Center, Department of Psychiatry and Neurology, Tulane University School of Medicine, New Orleans, LA 70112, USA
    J Int Med Res 34:339-47. 2006
  5. ncbi request reprint Cognitive components of deficit awareness in Alzheimer's disease
    Lisa M Duke
    Mental Health Service Line, Veterans Affairs Medical Center, New Orleans, Louisiana, USA
    Neuropsychology 16:359-69. 2002
  6. ncbi request reprint Donepezil: an update
    Ben Seltzer
    V A Boston Healthcare System, Department of Neurology, Harvard Medical School, Geriatric Research Center, Boston, MA 02130, USA
    Expert Opin Pharmacother 8:1011-23. 2007
  7. ncbi request reprint Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?
    Ben Seltzer
    Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA
    Drugs Aging 24:881-90. 2007

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: a comparative study
    B Seltzer
    Department of Psychiatry and Neurology, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA
    Neuropsychiatry Neuropsychol Behav Neurol 14:122-9. 2001
    ..To compare patients with Alzheimer disease (AD) and Parkinson disease (PD) with regard to their awareness of cognitive, emotional/social interaction, self-care, and motor-related neurologic deficits...
  2. ncbi request reprint Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial
    Ben Seltzer
    Department of Psychiatry and Neurology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112 2699, USA
    Arch Neurol 61:1852-6. 2004
    ..To evaluate the efficacy of donepezil in patients with early-stage Alzheimer disease...
  3. ncbi request reprint Donepezil: a review
    Ben Seltzer
    Tulane University School of Medicine, Department of Psychiatry and Neurology, 1430 Tulane Avenue HC82, New Orleans, Louisiana 70112, USA
    Expert Opin Drug Metab Toxicol 1:527-36. 2005
    ..Although donepezil was originally developed to inhibit the breakdown of the neurotransmitter acetylcholine as symptomatic therapy for AD, recent studies raise the possibility of other effects this drug has on the pathogenesis of AD...
  4. ncbi request reprint Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment
    B Seltzer
    Alzheimer s Disease and Memory Disorders Center, Department of Psychiatry and Neurology, Tulane University School of Medicine, New Orleans, LA 70112, USA
    J Int Med Res 34:339-47. 2006
    ..This article identifies barriers to early recognition and effective care of patients with Alzheimer's disease and discusses practical strategies to overcome them...
  5. ncbi request reprint Cognitive components of deficit awareness in Alzheimer's disease
    Lisa M Duke
    Mental Health Service Line, Veterans Affairs Medical Center, New Orleans, Louisiana, USA
    Neuropsychology 16:359-69. 2002
    ..AD patients may display intact immediate awareness of memory dysfunction but fail to incorporate incidents of memory failure into generalized self-belief systems...
  6. ncbi request reprint Donepezil: an update
    Ben Seltzer
    V A Boston Healthcare System, Department of Neurology, Harvard Medical School, Geriatric Research Center, Boston, MA 02130, USA
    Expert Opin Pharmacother 8:1011-23. 2007
    ..However, in general, the efficacy of donepezil is limited, and ongoing studies are investigating other agents that may ultimately overtake its present position as the mainstay of anti-AD therapy...
  7. ncbi request reprint Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?
    Ben Seltzer
    Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA
    Drugs Aging 24:881-90. 2007
    ..The most contentious issue regarding long-term treatment is economic, but the majority of available economic analyses suggest net savings over the long term if patients with AD receive persistent treatment with ChEIs...